We examined the efficacy of using attenuated non-replicating uracil auxotrophs that can be safely delivered as anticancer immunotherapeutics. This strategy exerted remarkable therapeutic activity in murine models of melanoma and ovarian carcinoma, and holds broad potential for the development of novel, highly effective anticancer vaccines.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862683 | PMC |
| http://dx.doi.org/10.4161/onci.26296 | DOI Listing |
Publication Analysis
Top Keywords
non-replicating reverses
4
reverses tumor-associated
4
tumor-associated immunosuppression
4
immunosuppression examined
4
examined efficacy
4
efficacy attenuated
4
attenuated non-replicating
4
non-replicating uracil
4
uracil auxotrophs
4
auxotrophs safely
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!